Biopol Chemicals (NSE:BIOPOL) EBIT: ₹ Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:BIOPOL Biopol Chemicals Ltd NSE:BIOPOL
20 GF Score
Price ₹97.80
! 4 Warning Signs
View Full Analysis

What is Biopol Chemicals EBIT?

Biopol Chemicals NSE:BIOPOL +0.31% 20 EBIT is ₹ Mil as of Mar. 2026. GuruFocus rates NSE:BIOPOL with a GF Score™ of 20/100. The stock has 4 warning signs investors should review.

Biopol Chemicals's earnings before interest and taxes (EBIT) for the six months ended in Mar. 2026 was ₹91.0 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Biopol Chemicals's annualized ROC % for the quarter that ended in Mar. 2026 was 31.72%. Biopol Chemicals's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 50.01%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield.

Biopol Chemicals  (NSE:BIOPOL) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Biopol Chemicals's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Mar. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=179.468 * ( 1 - 25.55% )/( (214.317 + 628.218)/ 2 )
=133.613926/421.2675
=31.72 %

where

Invested Capital(Q: Mar. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=314.753 - 88.953 - ( 11.483 - max(0, 172.549 - 312.017+11.483))
=214.317

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=697.753 - 64.351 - ( 5.184 - max(0, 147.312 - 550.18+5.184))
=628.218

Note: The Operating Income data used here is two times the semi-annual (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Biopol Chemicals's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Mar. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=181.978/( ( (2.233 + max(198.541, 0)) + (143.584 + max(383.481, 0)) )/ 2 )
=181.978/( ( 200.774 + 527.065 )/ 2 )
=181.978/363.9195
=50.01 %

where Working Capital is:

Working Capital(Q: Mar. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(166.564 + 118.143 + 15.827) - (88.953 + 0 + 13.04)
=198.541

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(277.869 + 196.076 + 22.754) - (64.351 + 0 + 48.867)
=383.481

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Biopol Chemicals's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=/1136.233
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biopol Chemicals EBIT Related Terms

Biopol Chemicals EBIT Historical Data

* Premium members only.

The historical data trend for Biopol Chemicals's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biopol Chemicals EBIT Chart

Biopol Chemicals Annual Data
Trend Mar24 Mar25 Mar26
EBIT
42.17 63.85 135.79

Biopol Chemicals Semi-Annual Data
Mar24 Mar25 Mar26
EBIT 0.00 44.13 90.99

NSE:BIOPOL vs LIN, SHW, ECL: EBIT Comparison

For the Specialty Chemicals subindustry, Biopol Chemicals's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biopol Chemicals EV-to-EBIT vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Biopol Chemicals's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Biopol Chemicals's EV-to-EBIT falls into.


NSE:BIOPOL
20GF Score
Biopol Chemicals Ltd NSE:BIOPOL
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biopol Chemicals EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹ Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of ₹ Mil mean?
Biopol Chemicals (NSE:BIOPOL) has a EBIT of ₹ Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Biopol Chemicals.
Is Biopol Chemicals' EBIT too high?
Biopol Chemicals' current EBIT is ₹ Mil. Overall, Biopol Chemicals has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Biopol Chemicals' EBIT compare to LIN and SHW?
Biopol Chemicals' EBIT of ₹ Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Chemicals company?
A good EBIT depends on the Chemicals industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Biopol Chemicals. Biopol Chemicals's current EBIT is ₹ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biopol Chemicals stock overvalued right now?
Biopol Chemicals (NSE:BIOPOL) has a current EBIT of ₹ Mil. The current EBIT is ₹ Mil. Biopol Chemicals' overall GF Score™ is 20/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Biopol Chemicals (NSE:BIOPOL), the current EBIT is ₹ Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biopol Chemicals Business Description

Address Street No 372 Action Area 1, Unit No 2ES3B1, 2nd Floor Mani Casadona, IIF Newtown Alia University, North 24 Parganas, Chakpachuria, New town, WB, IND, 700160
Biopol Chemicals Ltd is engaged in the business of trading, manufacturing and distribution of specialty chemicals under the categories of silicones, emulsifiers, biochemicals and polyelectrolytes. Its product portfolio consists of silicone-based products, emulsifier-based products, biochemical products and polyelectrolyte products. It serves various industry segments, including softeners, emulsions and hardeners for textiles; silicone fluids and cleaning chemicals for home care; silicone adjuvants and surfactants in agriculture; and release agents in industrial chemicals. The majority of the company's revenue is derived from the sale of its products to customers in the textile sector.
20GF Score

Get the complete analysis for NSE:BIOPOL

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹97.80
Price